Sunnyvale, CA, United States of America

Brian L Barcley

This inventor holds 1 USPTO granted patent. Top assignee: Alza Corporation. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Brian L. Barcley

Introduction

Brian L. Barcley is an accomplished inventor based in Sunnyvale, CA. He has made significant contributions to the field of pharmaceuticals, particularly in contraceptive technology. His innovative work has led to the development of a unique osmotic dosage form that combines an estrogen and a progestogen.

Latest Patents

One of Brian L. Barcley's notable patents is titled "Osmotic dosage form comprising an estrogen and a progestogen." This patent describes an osmotic device designed to deliver an estrogenic and a progestogenic steroid as a contraceptive pair for fertility regulation in females. This invention represents a significant advancement in contraceptive methods.

Career Highlights

Brian L. Barcley has worked at Alza Corporation, a company known for its pioneering work in drug delivery systems. His role at Alza has allowed him to focus on innovative solutions in the pharmaceutical industry. His expertise and dedication have contributed to the company's reputation for excellence in drug formulation.

Collaborations

Throughout his career, Brian has collaborated with notable colleagues, including Jeri D. Wright and Jerry D. Childers. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies in the field of pharmaceuticals.

Conclusion

Brian L. Barcley is a distinguished inventor whose work in osmotic dosage forms has made a lasting impact on contraceptive technology. His contributions continue to influence the pharmaceutical industry and improve women's health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…